Refocus Group Financials

Refocus Stock Summary

Refocus Group, Inc., a medical device company, engages in the research and development of treatments for human vision disorders, primarily for presbyopia. The company was founded in 1994 and is based in Dallas, Texas. Refocus operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 4 people.

Refocus Key Financial Ratios

There are many critical financial ratios that Refocus' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Refocus Group reports annually and quarterly.

Refocus Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Refocus's current stock value. Our valuation model uses many indicators to compare Refocus value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Refocus competition to find correlations between indicators driving Refocus's intrinsic value. More Info.Refocus Group is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Refocus' earnings, one of the primary drivers of an investment's value.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in private. Note that the Refocus Group information on this page should be used as a complementary analysis to other Refocus' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

If you are still planning to invest in Refocus Group check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Refocus' history and understand the potential risks before investing.